1. Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives

   • Yuqiu Han
   • Lanjuan Li
   • Baohong Wang

   Review 01 November 2022 Pages: 667 - 685

2. Recent advances in systemic lupus erythematosus and microbiota: from bench to bedside

   • Yijing Zhan
   • Qianmei Liu
   • Qianjin Lu

   Review 01 November 2022 Pages: 686 - 700

3. Targeting apoptosis to manage acquired resistance to third generation EGFR inhibitors

   • Shi-Yong Sun

   Review 24 September 2022 Pages: 701 - 713

4. New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria: a prospective cohort study

   • Jialu Wang
   • Shanshan Liu
   • Zhiyun Zhao

   Research Article 04 May 2022 Pages: 714 - 722

5. Increased expression of coronin-1a in amyotrophic lateral sclerosis: a potential diagnostic biomarker and therapeutic target

   • Qinming Zhou
   • Lu He
   • Sheng Chen

   Research Article 01 June 2022 Pages: 723 - 735

6. Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients with pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled study

   • Jiansheng Li
   • Hulei Zhao
   • Weiyu Zhang

   Research Article 22 April 2022 Pages: 736 - 744

7. Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach

   • Liang Dai
   • Jingjuan Xu
   • Guang Ji

   Research Article 26 April 2022 Pages: 745 - 759

8. Outcomes of patients awaiting lung transplantation after the implementation of donation after brain death at a single Chinese center

   • Yuling Yang
   • Xinnan Xu
   • Wenxin He

   Research Article 01 July 2022 Pages: 760 - 765

9. Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202)

   • Jianhua Shi
   • Ying Cheng
   • Xiaoling Li

   Research Article 16 July 2022 Pages: 766 - 772

10. Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

    • Kaili Yang
    • Jiarui Li
    • Chunmei Bai

    Research Article 01 July 2022 Pages: 773 - 783

11. Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in GNAQ/11-mutant uveal melanoma

    • Yan Zhang
    • Baoyuan Zhang
    • Ruibao Ren

    Research Article 23 August 2022 Pages: 784 - 798

12. Mycophenolate mofetil or tacrolimus compared with azathioprine in long-term maintenance treatment for active lupus nephritis

    • Qianying Zhang
    • Peng Xing
    • Nan Chen

    Research Article 18 March 2022 Pages: 799 - 807

13. Novel variants in LAMA3 and COL7A1 and recurrent variant in KRT5 underlying epidermolysis bullosa in five Chinese families

    • Rongrong Wang
    • Liwei Sun
    • Xue Zhang

    Letter to Frontiers of Medicine 21 March 2022 Pages: 808 - 814

14. Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)

    • Suning Chen
    • Weili Zhao
    • Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association

    Consensus 24 September 2022 Pages: 815 - 826